Exane Derivatives’s Seagen Inc. Common Stock SGEN Stock Holding History

Exane Derivatives’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$153K	Sell	864 -607	-41%	-$87.5K	0.09%	204
2022 Q1	$212K	Sell	1,471 -194	-12%	-$26.2K	0.06%	316
2021 Q4	$257K	Sell	1,665 -215	-11%	-$36K	0.06%	291
2021 Q3	$319K	Sell	1,880 -72	-4%	-$11.2K	0.08%	272
2021 Q2	$281K	Sell	1,952 -339	-15%	-$50.4K	0.06%	304
2021 Q1	$318K	Sell	2,291 -740	-24%	-$119K	0.09%	208
2020 Q4	$531K	Buy	3,031 +2,315	+323%	+$432K	0.16%	144
2020 Q3	$140K	Sell	716 -69	-9%	-$11.6K	0.04%	245
2020 Q2	$133K	Sell	785 -215	-22%	-$32.1K	0.04%	251
2020 Q1	$115K	Buy	+1,000	New	+$111K	0.03%	268

Other funds holding SGEN

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Exane Derivatives's SGEN Position: Q2 2022 in Review

Exane Derivatives reduced its Seagen Inc. Common Stock (SGEN) stake by 41% in Q2 2022, selling an estimated $87.5K and leaving 864 shares worth $153K. The position accounts for 0.09% of the portfolio, ranked #204.

Exane Derivatives first reported a position in SGEN in Q1 2020 and has held it in 10 quarters since. The position peaked at $531K in Q4 2020. 548 funds tracked by Wall St. Rank hold SGEN as of Q2 2022.

Exane Derivatives held 864 shares of Seagen Inc. Common Stock worth $153K as of Q2 2022.
Exane Derivatives sold 607 Seagen Inc. Common Stock shares in Q2 2022, an estimated $87.5K.
Seagen Inc. Common Stock made up 0.09% of Exane Derivatives's portfolio in Q2 2022, its #204 holding.
Exane Derivatives first reported a position in Seagen Inc. Common Stock in Q1 2020 and has held it in 10 quarters since.
Exane Derivatives's Seagen Inc. Common Stock position peaked at $531K in Q4 2020.
548 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.